FOR IMMEDIATE RELEASE
inSeption Group Congratulates Dawn Niccum on Election to the SQA Board of Directors
[Audubon, PA – December 9, 2025] — inSeption Group is delighted to announce that our own Dawn Niccum, RN, MSN, CCRA, RQAP-GCP, has been elected to the 2026 Board of Directors of the Society of Quality Assurance (SQA).
As inSeption’s Executive Vice President, Quality Assurance, Dawn has long upheld the highest standards for clinical quality, compliance, inspection readiness, and GCP best practices.
With her election to the SQA Board, Dawn will help support and expand the Society’s mission of providing high-quality education, training, and professional development opportunities for its members. Her depth of experience in clinical research, quality systems, and regulatory compliance positions her to contribute meaningfully to initiatives that strengthen knowledge sharing and elevate standards across the QA community.
“Dawn’s election to the SQA Board of Directors is a testament to her expertise and longstanding commitment to advancing quality in our industry,” said Joseph Arcangelo, Managing Partner and Co-Founder of inSeption Group. “Her leadership will contribute meaningfully to SQA’s educational mission and the continued growth of the QA community.”
Dawn added: “I am honored to have been elected to serve the membership of SQA as a member of the Board of Directors. SQA has been a critical contributor to my growth as a QA professional, and I look forward to this opportunity to give back to SQA. I believe strongly in SQA’s mission and in inSeption’s foundational commitment to excellence.”
About inSeption Group
inSeption Group is a clinical outsourcing organization supporting sponsors in drug development and regulatory submissions through expert-led teams and a model that prioritizes quality, agility, and deep scientific engagement. With extensive experience in complex therapeutic areas and a strong culture of ownership and integrity, inSeption delivers solutions that consistently exceed expectations.
For media inquiries, contact:
Kristin Morris
Senior Director, Corporate Communications
267-397-8980
kmorris@inseptiongroup.com
inseptiongroup.com